Jim Simons

Jim Simons Renaissance Technologies

AUM $75.2B
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Quarter Return
+6.82%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$97.3B
AUM Growth
+$97.3B
Cap. Flow
+$1.24B
Cap. Flow %
1.27%
Top 10 Hldgs %
9.68%
Holding
3,734
New
509
Increased
1,627
Reduced
1,174
Closed
411

Sector Composition

1 Healthcare 17.74%
2 Technology 14.99%
3 Financials 10.9%
4 Consumer Discretionary 8.96%
5 Real Estate 8.48%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
VRSN icon
1
VeriSign
VRSN
$25.4B
$1.13B 1.16% 7,037,800 +122,700 +2% +$19.6M
ALGN icon
2
Align Technology
ALGN
$10.3B
$1.09B 1.12% 2,778,381 -116,419 -4% -$45.5M
HUM icon
3
Humana
HUM
$36.2B
$1.07B 1.1% 3,174,800 +391,300 +14% +$132M
PANW icon
4
Palo Alto Networks
PANW
$127B
$1.05B 1.08% 4,651,200 +925,500 +25% +$208M
DPZ icon
5
Domino's
DPZ
$15.5B
$939M 0.96% 3,183,800 -267,700 -8% -$78.9M
NVO icon
6
Novo Nordisk
NVO
$250B
$927M 0.95% 19,666,671 +524,371 +3% +$24.7M
AMGN icon
7
Amgen
AMGN
$154B
$853M 0.88% 4,115,145 +311,545 +8% +$64.6M
VMW
8
DELISTED
VMware, Inc
VMW
$802M 0.82% 5,136,168 -153,632 -3% -$24M
VRTX icon
9
Vertex Pharmaceuticals
VRTX
$100B
$788M 0.81% 4,089,117 +38,500 +1% +$7.42M
ABMD
10
DELISTED
Abiomed Inc
ABMD
$773M 0.79% 1,719,023 +167,600 +11% +$75.4M
PEP icon
11
PepsiCo
PEP
$203B
$740M 0.76% 6,620,250 -342,600 -5% -$38.3M
PGR icon
12
Progressive
PGR
$145B
$605M 0.62% 8,511,700 +1,416,800 +20% +$101M
CCI icon
13
Crown Castle
CCI
$42.8B
$602M 0.62% 5,405,300 +115,597 +2% +$12.9M
NVDA icon
14
NVIDIA
NVDA
$4.26T
$588M 0.6% 2,091,465 +601,672 +40% +$169M
BMY icon
15
Bristol-Myers Squibb
BMY
$95.6B
$580M 0.6% 9,344,000 -1,203,200 -11% -$74.7M
MOH icon
16
Molina Healthcare
MOH
$9.7B
$556M 0.57% 3,738,755 +932,905 +33% +$139M
BP icon
17
BP
BP
$90.7B
$550M 0.57% 11,921,446 +2,863,902 +32% +$132M
META icon
18
Meta Platforms (Facebook)
META
$1.86T
$548M 0.56% 3,332,556 +865,068 +35% +$142M
DUK icon
19
Duke Energy
DUK
$95.7B
$484M 0.5% 6,051,129 +1,980,562 +49% +$158M
DELL icon
20
Dell
DELL
$82.9B
$483M 0.5% 4,974,600 -575,100 -10% -$55.9M
FE icon
21
FirstEnergy
FE
$25.3B
$458M 0.47% 12,312,308 +304,900 +3% +$11.3M
AZPN
22
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$456M 0.47% 4,002,003 +139,203 +4% +$15.9M
IDXX icon
23
Idexx Laboratories
IDXX
$51.5B
$444M 0.46% 1,778,004 -391,925 -18% -$97.8M
CL icon
24
Colgate-Palmolive
CL
$67.7B
$444M 0.46% 6,627,800 -573,100 -8% -$38.4M
CBOE icon
25
Cboe Global Markets
CBOE
$24.5B
$439M 0.45% 4,570,700 -619,500 -12% -$59.4M